Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1946 1
1968 1
1972 2
1974 1
1975 2
1977 2
1978 2
1979 1
1981 3
1982 2
1983 2
1984 6
1985 7
1986 3
1987 11
1988 10
1989 10
1990 14
1991 7
1992 14
1993 16
1994 27
1995 30
1996 39
1997 41
1998 36
1999 53
2000 53
2001 71
2002 79
2003 110
2004 138
2005 139
2006 175
2007 207
2008 212
2009 262
2010 331
2011 391
2012 513
2013 616
2014 735
2015 878
2016 903
2017 1012
2018 1139
2019 1385
2020 1612
2021 1955
2022 2373
2023 2342
2024 1010

Text availability

Article attribute

Article type

Publication date

Search Results

17,003 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: yao y. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Recent advances in CRISPR-Cas9-based genome insertion technologies.
Chen X, Du J, Yun S, Xue C, Yao Y, Rao S. Chen X, et al. Among authors: yao y. Mol Ther Nucleic Acids. 2024 Feb 5;35(1):102138. doi: 10.1016/j.omtn.2024.102138. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38379727 Free PMC article. Review.
Chimeric nanobody-decorated liposomes by self-assembly.
Rahman MM, Wang J, Wang G, Su Z, Li Y, Chen Y, Meng J, Yao Y, Wang L, Wilkens S, Tan J, Luo J, Zhang T, Zhu C, Cho SH, Wang L, Lee LP, Wan Y. Rahman MM, et al. Among authors: yao y. Nat Nanotechnol. 2024 Feb 19. doi: 10.1038/s41565-024-01620-6. Online ahead of print. Nat Nanotechnol. 2024. PMID: 38374413
Mechanisms of angiogenesis in tumour.
Zhang R, Yao Y, Gao H, Hu X. Zhang R, et al. Among authors: yao y. Front Oncol. 2024 Mar 25;14:1359069. doi: 10.3389/fonc.2024.1359069. eCollection 2024. Front Oncol. 2024. PMID: 38590656 Free PMC article. Review.
PD-1 regulation in immune homeostasis and immunotherapy.
Gao M, Shi J, Xiao X, Yao Y, Chen X, Wang B, Zhang J. Gao M, et al. Among authors: yao y. Cancer Lett. 2024 Apr 28;588:216726. doi: 10.1016/j.canlet.2024.216726. Epub 2024 Feb 23. Cancer Lett. 2024. PMID: 38401888 Review.
Functional nanoporous graphene superlattice.
Lv H, Yao Y, Yuan M, Chen G, Wang Y, Rao L, Li S, Kara UI, Dupont RL, Zhang C, Chen B, Liu B, Zhou X, Wu R, Adera S, Che R, Zhang X, Wang X. Lv H, et al. Among authors: yao y. Nat Commun. 2024 Feb 12;15(1):1295. doi: 10.1038/s41467-024-45503-9. Nat Commun. 2024. PMID: 38346953 Free PMC article.
Declined terrestrial ecosystem resilience.
Yao Y, Liu Y, Fu F, Song J, Wang Y, Han Y, Wu T, Fu B. Yao Y, et al. Glob Chang Biol. 2024 Apr;30(4):e17291. doi: 10.1111/gcb.17291. Glob Chang Biol. 2024. PMID: 38647225
Application of Multifunctional Nanozymes in Tumor Therapy.
Shao L, Wang X, Du X, Yin S, Qian Y, Yao Y, Yang L. Shao L, et al. Among authors: yao y. ACS Omega. 2024 Mar 26;9(14):15753-15767. doi: 10.1021/acsomega.4c00258. eCollection 2024 Apr 9. ACS Omega. 2024. PMID: 38617672 Free PMC article. Review.
Phase Engineering of Nanomaterials: Transition Metal Dichalcogenides.
Zhai W, Li Z, Wang Y, Zhai L, Yao Y, Li S, Wang L, Yang H, Chi B, Liang J, Shi Z, Ge Y, Lai Z, Yun Q, Zhang A, Wu Z, He Q, Chen B, Huang Z, Zhang H. Zhai W, et al. Among authors: yao y. Chem Rev. 2024 Apr 10;124(7):4479-4539. doi: 10.1021/acs.chemrev.3c00931. Epub 2024 Mar 29. Chem Rev. 2024. PMID: 38552165 Review.
Advances in prognostic models for osteosarcoma risk.
Yao Y, Wang D, Zheng L, Zhao J, Tan M. Yao Y, et al. Heliyon. 2024 Mar 26;10(7):e28493. doi: 10.1016/j.heliyon.2024.e28493. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38586328 Free PMC article. Review.
17,003 results
You have reached the last available page of results. Please see the User Guide for more information.